AINewsnow

Carcinoid Syndrome Diarrhea Treatment Market Growth Driven by Advanced Neuroendocrine Tumor Therapies

This story is from 2026-09-28. It is preserved in the archive; the latest stories are on the live feed.

The global carcinoid syndrome diarrhea treatment market was valued at USD 4.63 billion in 2025 and is projected to grow from USD 5.02 billion in 2026 to USD 9.57 billion by 2034, registering a CAGR of 8.4% during 2026–2034. North America dominated the market with a 41.6% share in 2025, while Asia P…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-09-28 12:48 · DEV Community — AI
    Carcinoid Syndrome Diarrhea Treatment Market Growth Driven by Advanced Neuroendocrine Tumor Therapies

More stories

  1. NVIDIA Open Agent Safety Platform: A Reference for Continuous In-Silicon Agent Monitoring — NVIDIA Technical Blog
  2. Launching Meta Enterprise Platform — Meta Newsroom
  3. Unsecured OpenAI agents posted 53 user images on the internet without the lab's knowledge — TechCrunch AI
  4. Heads of OpenAI and Anthropic called to face Senate inquiry after rogue agent incidents — The Guardian AI
  5. Scoop: Top AI companies probing tens of thousands of security incidents — Axios AI+
  6. Bill Gates says unchecked AI could ‘cause a billion deaths’ in call for regulation — The Guardian AI
  7. Scoop: Anthropic's Dario Amodei to have White House dinner with Trump — Axios AI+
  8. OpenAI bots meddled with multiple US government agency sites — BBC Technology

Get the daily brief of stories like this at 6:30 every morning →